Introduction {#s0001}
============

BushenHuoxue Decoction (BSHXD), which is applied to treat osteoarthritis (OA), originates from a commonly used recipe for Jiangsu Province Hospital of Traditional Chinese Medicine. BSHXD was composed of *Angelicae Pubescentis Radix, Taxilli Herba, Achyranthis Bidentatae Radix, Epimedii Folium, Angelicae Sinensis Radix, Chuanxiong Rhizoma, Paeoniae Radix Alba, Polygoni Cuspidati Rhizoma Et Radix,* and *Arisaematis Rhizoma Preparatum.*

OA which is also called hypertrophic arthritis or degenerative arthritis was frequently occurred and refractory. It is expressed by arthralgia, stiffness, and deformity (Zhang et al. [@CIT0027]; Juhl et al. [@CIT0012]). Depending on the basic theories of Chinese medicine, it is a type of bone obstruction disease. The principal pathological symptom of OA is lesion of cartilage tissue. Cytokine plays an important role in the pathogenesis of OA by promoting catabolism of cartilage matrix (Schable [@CIT0021]; Yang et al. [@CIT0024]; Cornejo et al. [@CIT0006]).

High-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry (HPLC-ESI-Q-TOF-MS) was established for qualitative analysis on chemical compounds of BSHXD. Eighty-eight compounds were confirmed by comparing its retention time and MS spectrum with the corresponding reference compound. Through the review of literature, 12 active compounds with potential in treating OA and inhibiting chondrocyte apoptosis were found from these 88 compounds. UPLC-ESI-TQ-MS method was also established to simultaneously determine and compare the contents of these 12 compounds in BSHXD and in single herb decoction. The results showed that the contents of five compounds, which were quercetin, isopsoralen, icariside II, osthole, and isoimperatorin, increased remarkably in BSHXD. To evaluate the anti-inflammatory activity and explore the therapeutic mechanism of BSHXD against OA, the effect of above five compounds on TNF-α, IL-6, and NO released by macrophage was assayed.

Materials and methods {#s0002}
=====================

Chemicals, reagents, and samples {#s0003}
--------------------------------

The reference compounds of catechin (no. 10144-201209), paeoniflorin (no. 0736-9811), hyperoside (no. 10228-201204), ferulic acid (no. 0773-9910), polydatin (no. 10201-201209), quercetin (no. 081-9003), resveratrol (no. 10040-201201), psoralen (no. 739-8701), isopsoralen (no. 0739-200108), icariside II (no. 20264-201201), osthole (no. 0822-9802), and isoimperatorin (no. 10531-201203) were obtained from the National Institutes for the Control of Pharmaceutical and Biological Products (Beijing, China). LPS (1 mg/mL, Sigma-Aldrich, St. Louis, MO), 1640 medium (Gibico, Waltham, MA), FBS (Sijiqing Co., Ltd, Shanghai, China), Pancreatin (no. 27250018, Gibico, Waltham, MA), DMSO (no. 20110105, Lingfeng Co., Ltd, Shanghai, China), TNF-α ELISA kit (no. EM004-96, 96t, Kesai Biological Products Co., Shanghai, China), IL-6 ELISA kit (no. EM008-96, 96t, Kesai Biological Products Co., Shanghai, China), and NO kit (no. S0021-2, 200t, Beyotime Institute of Biotechnology, Jiangsu, China).

Methanol and acetonitrile were of HPLC grade and purchased from Hanbang Technology Co., Ltd. (Jiangsu, China). Ultra-pure water was obtained by the EPED super-purification system (Nanjing EPED Co., Ltd, Nanjing, China). All other chemicals and solvents used in this study were of analytical grade. The herbal materials were purchased in June 2011 from Bozhou Medicinal Material Company (Bozhou, China) and authenticated by Prof. Jianwei Chen of Nanjing University of Chinese Medicine, Nanjing, China. Voucher specimens were deposited at Key Laboratory of Famous Doctors\' Proved Recipe Evaluation and Transformation of State Administration of Traditional Chinese Medicine.

Instrument and LC-MS/MS conditions {#s0004}
==================================

Instruments {#s0005}
-----------

RE-52A rotary evaporator (Shanghai Yarong Biochemistry Instrument Factory, Shanghai, China), hypothermia centrifugal machine (model TGL16, Changsha Xiangzhi, Changsha, China), water bath (model SY-1220, Crystal, Santa Clara, CA), super clean bench (model 1300 SERIES A2, Thermo Scientific, Waltham, MA), CO~2~ incubator (Thermo Scientific SERIES II WATER JACKET), and enzyme-labelling instrument (Thermo Scientific, Waltham, MA).

Chromatographic conditions {#s0006}
--------------------------

HPLC analysis was performed on a Shimadzu LC-20A HPLC system (Shimadzu, Kyoto, Japan) equipped with a binary pump, an online degasser, an autosampler, and a column oven, using a Hanbon Lichrospher^TM^ HPLC C18 column (4.6 × 250 mm, 5 μm). The mobile phase was methanol (A) and 0.1% aqueous formic acid (v/v, B), with a gradient elution of 10% A in 0--5 min, 10--30% A in 5--10 min, 30--85% A in 10--15 min, 85--100% A in 15--20 min, 100% A in 20--23 min, 100--10% A in 23--30 min, at a flow rate of 1.0 mL/min, the injection volume was 10 μL, and the temperature of the column was maintained at 40 °C.

UPLC analysis was performed on a Waters ACQUITY UPLC system (Waters, Milford, MA) equipped with a binary pump, an online degasser, an autosampler, and a column oven, using a BEH C18 column (2.1 × 100 mm I.D., 1.7 μm, Waters, Milford, MA). The mobile phase consisted of 0.1% aqueous formic acid (v/v, A) and acetonitrile (B), with a gradient program of 90--65% A in 0--7 min, 65--40% A in 7--11 min, 40--0% A in 11--14 min, 0--0% A in 14--17 min, 0--90% A in 17--18 min, at a flow rate was 0.4 mL/min, the injection volume was 2 μL, and the temperature of the column was maintained at 35 °C.

Mass-spectrometry conditions {#s0007}
----------------------------

The qualitative analysis was performed on an AB SCIEX Triple Tof 5600 (AB SCIEX, Foster City, CA) equipped with an electrospray ionization (ESI) source, and the ESI source was set in positive and negative mode. The scanning mode was set in multiple reaction monitoring (MRM) mode. The ion spray (IS) voltage was set at −4500.00 V; declustering potential (DP), −80 V; collision (CE), −30.0 V; ion source gas 1, 55.00 psi; ion source gas 2, 55.00 psi; CUR, 40.00 psi; TEM, 500.00 °C; TOF MASSES (DA), Min =100.0000, Max =1200.0000; collisional excitation scanning (CES), 20.0.

The quantitative analysis was performed on a Waters-Xevo TQ, tri-stage quadrupole mass spectrometer system (Waters, Milford, MA) equipped with an ESI source, and the ESI source was set in positive and negative mode. The scanning mode was established in MRM mode. The capillary voltage was 3 kV, ion source temperature was 150 °C, the dry gas flow was 1000 L/h, dry heater was 550 °C, the cone gas flow was 50 L/h, and the collision gas flow was 0.15 mL/min.

Preparation of sample solutions for LC-MS/MS analysis {#s0008}
-----------------------------------------------------

*Angelicae Pubescentis Radix* 400 g, *Taxilli Herba* 400 g*, Achyranthis Bidentatae Radix* 600 g*, Epimedii Folium* 600 g*, Angelicae Sinensis Radix* 600 g*, Chuanxiong Rhizoma* 600 g*, Paeoniae Radix Alba* 600 g*, Polygoni Cuspidati Rhizoma Et Radix* 600 g, and *Arisaematis Rhizoma Preparatum* 600 g were mixed together. The mixture was decocted with 30 L water three times (1, 1, and 0.5 h). The filtrates from each decoction were consolidated and concentrated to 1000 mL, and added 1100 mL 95% ethanol, suspension was centrifuged at 5000 rpm for 10 min after 48 h standing. The supernatant was dried on a water bath, and dissolved 0.0001 g dried supernatant in 50% methanol to 100 mL, then filtered through 0.22 μm membrane filter to produce stock solutions. The reference compounds were accurately weighed and dissolved in 50% methanol to produce stock reference solutions. The above stock solutions was stored at 4 °C and brought to room temperature before use.

Enzyme-linked immunosorbent assay {#s0009}
=================================

Cell culture {#s0010}
------------

The murine macrophages RAW264.7 were cultured in 1640 culture medium with 10% FBS in an incubator containing 5% CO~2~ at 37 °C. The cells were digested with trypsin when they grew to an appropriate amount, and placed into the wells of a 48-well plate at 200 μL/well (1 × 10^5^ cells/well) and cultured for 24 h in the sterilized incubator.

Grouping and administration {#s0011}
---------------------------

LPS was diluted with 1640 culture medium to 500 ng/mL, BSHXD and compound samples were dissolved in DMSO at 1 × 10^5^ μg/mL and diluted to 100 and 20 μg/mL with the culture medium. Above samples were added to each of control group, LPS group, and sample groups (LPS + sample 20 μg/mL, LPS + sample 100 μg/mL) in an amount of 300 μL. The 48-well plate was incubated another 24 h in the sterilized incubator.

Sample detection {#s0012}
----------------

The supernatant was collected after centrifuging at 10,000 rpm for 2 min at 4 °C. The supernatant was treated and the absorbance was measured at 450 nm (TNF-α, IL-6) and 540 nm (NO) using an enzyme-labelling instrument according to the instruction of the manufacturer, respectively. Cytokine concentrations were calculated by a calibration curve prepared by standard concentrations as *X*-axis, and OD values as *Y*-axis.

Data analysis {#s0013}
-------------

Inhibitory rate (%) = 100%− (*C*~LPS + sample~−*C*~LPS~)/(*C*~LPS~−*C*~untreated~), *C* is the cytokine concentration. All samples were assayed in triplicate. The results were presented as means ± standard deviations (SD). Statistical analyses were performed using a one-way analysis of variance ANOVA test (SPSS v.16.0, SPSS Inc., Chicago, IL), followed by Student's two-tailed unpaired *t-*test. *p* \< 0.05 was considered as the statistically significant.

Results and discussion {#s0014}
======================

Optimization of ion condition {#s0015}
-----------------------------

In order to determine appropriate ion condition for Q-TOF and TQ mass spectrometer, all the analytes were detected under affuse mode, and the fragment ions were automatically collected under MRM scanning mode, with optimal cone voltage and collision energies.

Selection of mobile phases {#s0016}
--------------------------

A series of experiments were carried out with different mobile phases, for example methanol/water, methanol/acetonitrile--water, methanol/acetonitrile--0.1% formic acid--water, methanol/acetonitrile--0.05% aqueous formic acid. It turned out that the best chromatographic peak was obtained when using methanol--0.1% aqueous formic acid solution and 0.1% aqueous formic acid solution--acetonitrile as the mobile phases for HPLC-ESI-Q-TOF-MS and UPLC-ESI-TQ-MS, respectively.

Qualitative analysis {#s0017}
--------------------

Qualitative analysis on compounds in BSHXD was achieved by HPLC-ESI-Q-TOF-MS, the total ion flow chart of positive and negative ion modes is shown in [Figure 1](#F0001){ref-type="fig"}. These peaks showed different molecular ion the MS^2^ spectra, which exhibited a fragmentation pathway. According to measured molecular weight, theoretical molecular weight, fragment ion, elemental analysis, and compared with relevant literature data, 88 compounds from BSHXD were detected and confirmed. The mass error for molecular ions was in ±5 ppm. The detailed spectral data are presented in [Table 1](#t0001){ref-type="table"}. The results provided some evidence of the material basis for the BSHXD.

![Total ion flow chart of positive ion (A) and negative ion (B) mode in BSHXD.](IPHB_A_1285327_F0001_C){#F0001}

###### 

Qualitative analysis on chemical compounds in BSHXD.

               Negative ion (*m/z*)   Positive ion (*m/z*)                                                                                              
  ---- ------- ---------------------- ---------------------- ------- ---------- ---------- ------- ------------------------------- -------------------- ------------------------------------------
  1    1.82                                                          175.1186   175.119    −0.23   (+)130,116,112                  C~6~H~14~N~4~O~2~    Arginine
  2    2.18    341.1091               341.1089               0.06    365.1053   365.1054   −0.03   (−)221,179,161,119,113,(+)203   C~12~H~22~O~11~      Sucrose
  3    2.29    179.0571               179.0561               0.59                                  (−)131,101                      C~6~H~12~O~6~        Glucose
  4    2.3     179.0576               179.0561               0.84                                  (−)161,134                      C~6~H~12~O~6~        Inositol
  5    2.34                                                          118.0863   118.0863   0       (+) 118                         C~5~H~11~NO~2~       Valine
  6    2.38                                                          138.0548   138.055    −0.14   (+) 120                         C~7~H~7~NO~2~        Trigonelline
  7    2.38                                                          176.1025   176.103    −0.28   (+) 130,                        C~6~H~13~N~3~O~3~    Citrulline
  8    2.49                                                          144.1007   144.1019   −0.83   (+) 102                         C~7~H~13~NO~2~       Stachydrine
  9    2.81                                                          156.0761   156.0768   −0.45   (+) 110                         C~6~H~9~N~3~O~2~     [L]{.smallcaps}-Histidine
  10   2.86    243.0632               243.0636               −0.16                                 (−)130,110                      C~9~H~12~N~2~O~6~    Uridine
  11   3.7     169.0152               169.0143               0.53                                  (−)125,107                      C~7~H~6~O~5~         Gallic acid
  12   6.52    153.0213               153.0193               1.3                                   (−)108                          C~7~H~6~O~4~         2,4-Dihydroxybenzoic acid
  13   7.75    543.1173               543.1178               −0.09                                 (−)421,259,121                  C~23~H~28~O~13~S     Paeoniflorin sulphurous acid ester
  14   8.52                                                          127.04     127.039    0.79    (+)109                          C~6~H~6~O~3~         5-Hydroxymethyfurfural
  15   8.65                                                          268.1032   268.1027   0.18    (+)136,119                      C~10~H~13~N~5~O~4~   Adenosine
  16   9.04    495.15                 495.1508               −0.16   519.1501   519.1473   0.54    (−)333,281,137 (+)357           C~23~H~28~O~12~      Oxypaeoniflora
  17   9.49    289.0736               289.0718               0.62                                  (−)245,203,123,                 C~15~H~14~O~6~       Cianidanol
  18   10.2    183.0312               183.0299               0.71                                  (−)124                          C~8~H~8~O~5~         Methyl gallate
  19   10.2    183.031                183.0299               0.6                                   (−) 140,124                     C~7~H~6~O~3~         4-Hydroxybenzoic acid
  20   11.02   563.1412               563.1406               0.11                                  (−)383,353                      C~26~H~28~O~14~      Isoschaftoside
  21   11.07   210.0785               210.0761               0                                     (−) 164,124,                    C~9~H~11~NO~2~       Phenylalanine
  22   11.73   525.1615               525.1603               0.23                                  (−)449,327,165,121              C~23~H~28~O~11~      Paeoniflorin
  23   12.23   463.0896               463.0882               0.3                                   (−)300                          C~21~H~20~O~12~      Hyperoside
  24   12.29   525.307                525.3058               0.23                                  (−)479,319,159                  C~27~H~44~O~7~       Hydroxyecdyone
  25   12.29   447.09                 447.0933               −0.74                                 (−) 356,285                     C~21~H~20~O~11~      Astragalin
  26   12.44   525.3071               525.3058               0.25                                  (−)479                          C~27~H~44~O~7~       Rhapontisterone
  27   12.77   197.0471               197.0444               1.4                                   (−)169,162,152,124              C~8~H~8~O~3~         Vanillin
  28   13.04   807.2765               807.2717               0.59                                  (−)645,514,351                  C~38~H~48~O~19~      Epimedin B
  29   13.25   193.0517               193.0506               0.57    217.0467   217.0471   −0.18   (−)121(+)134                    C~10~H~10~O~4~       Ferulic acid
  30   13.3    525.1606               525.1603               0.06                                  (−)479,357,121                  C~23~H~28~O~11~      Albiflorin
  31   13.33   389.1267               389.1242               0.64                                  (−)227,185,143                  C~20~H~22~O~8~       Polydatin
  32   13.56   837.2856               837.2881               −0.31                                 (−)675                          C~39~H~50~O~20~      Epimedin A
  33   13.56   867.2963               867.2917               0.53                                  (−)679,367                      C~39~H~50~O~19~      Epimedin C
  34   13.58   675.2321               675.2294               0.4                                   (−)366,351                      C~33~H~40~O~15~      Icariin
  35   14.21   431.0988               431.0984               0.09    455.0946   455.0949   −0.07   (−)269,225 (+)293,185,164       C~21~H~20~O~10~      Apigenin-7-*O*-2te2glucopyranoside
  36   14.23   431.1015               431.0984               0.72    455.0969   455.0973   −0.88   (−)269,225 (+)293,185           C~21~H~20~O~10~      Emodin-8-*O*-β-[d]{.smallcaps}-glucoside
  37   14.26   955.4958               955.4908               0.52                                  (−)793                          C~48~H~76~O~19~      Ginsenoside-Ro
  38   14.31   285.0409               285.0405               0.14                                  (−)133                          C~15~H~10~O~6~       Luteolin
  39   14.35   301.0354               301.036                −0.2                                  (−)282,229,151                  C~15~H~10~O~7~       Quercetin
  40   14.66   629.1877               629.1865               0.19    607.1845   607.1786   0.97    (−)583, (+)607,341,289,105      C~30~H~32~O~12~      Benzoylpaeoniflorin
  41   14.99   299.056                299.0561               0.03                                  (−)284                          C~16~H~12~O~6~       Kaempferol
  42   15.01   299.0558               299.055                0.27                                  (−)284                          C~15~H~10~O~4~       Chrysophonal
  43   15.01   299.0558               299.0561               −0.1                                  (−)284                          C~16~H~12~O~6~       Fallacinol
  44   15.07                                                         215.0324   215.0315   0.42    (+)140                          C~10~H~8~O~4~        Scopoletin
  45   15.62                                                         229.0861   229.0859   0.87    (+)211,165,152,135,119,107      C~14~H~12~O~3~       Resveratrol
  46   16.04   513.1787               513.1766               0.41                                  (−)366,351,323                  C~27~H~30~O~10~      IcarisideII
  47   16.11                                                         247.0656   247.0577   3.2     (+) 140,105                     C~11~H~12~O~5~       Sinapic
  48   16.14   205.0884               205.087                0.68                                  (−)161                          C~12~H1~4~O~3~       Chuanxiongol
  49   16.46   323.2234               323.2228               0.19                                  (−)305,265                      C~18~H~30~O~2~       Linolenic acid
  50   16.51                                                         211.0648   211.0754   −5.01   (+)181,163,135,120, 105         C~12~H~12~O~2~       *n*-Butylidenephthalide
  51   16.52   283.0624               283.0612               0.42                                  (−)240,212,183                  C~16~H~12~O~5~       Physcion
  52   16.55                                                         247.0941   247.0946   −0.2    (+)229,113                      C~12~H~16~O~4~       SenkyunolideI
  53   16.61                                                         217.0508   217.0495   0.6     (+)152,123                      C~12~H~8~O~4~        Isobergapten
  54   16.63                                                         163.0411   163.039    1.3     (+)135,107,105                  C~9~H~6~O~3~         Umbelliferone
  55   16.66                                                         269.0828   269.0784   1.6     (+)205,188                      C~14~H~14~O~4~       Columbianetin
  56   16.66   241.1441               241.1434               0.27                                  (−)225,197                      C~12~H~20~O~2~       [l]{.smallcaps}-Bornyl acetate
  57   16.79                                                         187.0412   187.039    1.2     (+)131,115                      C~11~H~6~O~3~        Psoralen
  58   16.85   269.0831               269.0819               0.45                                  (−)254,225,210                  C~16~H~14~O~4~       Imperatorin
  59   16.85   251.1652               251.1642               0.41                                  (−)152,133                      C~14~H~22~O          2,6-Di-*tert*-butylphenol
  60   16.9    251.167                251.1641               1.12                                  (−)209,151                      C~14~H~22~O          2,4-Di-*tert*-butylphenol
  61   16.98   255.0674               255.0663               0.43                                  (−)201,166                      C~15~H~12~O~4~       Isoliquiritigenin
  62   17.03                                                         284.0973   284.0989   −0.56   (+) 239,185                     C~10~H~13~N~5~O~5~   Guanosine
  63   17.04                                                         187.0421   187.039    1.66    (+)118                          C~11~H~6~O~3~        Isopsoralen
  64   17.31   239.13                 239.1278               0.92                                  (−)223,195,139                  C~12~H~18~O~2~       Sedanolide
  65   17.43                                                         217.0509   217.0495   0.65    (−)202,174,145                  C~12~H~8~O~4~        Bergapten
  66   17.65   269.0823               269.0819               0.15                                  (−)241,225                      C~16~H~14~O~4~       Isoimperatorin
  67   17.66   269.0465               269.0455               0.37                                  (−)241,225                      C~15~H~10~O~5~       Frangulic acid
  68   17.75   269.0469               269.0455               0.52                                  (−)225                          C~15~H~10~O~5~       Apigenin
  69   17.79   315.2445               315.2541               −3                                    (−)297,279,171,141              C~17~H~34~O~2~       Heptadecanoic
  70   17.8    315.2562               315.2529               1                                     (−)297,279                      C~17~H~34~O~2~       Methyl palmitate
  71   17.95                                                         193.1224   193.1223   0.05    (+)175,147,137,105              C~12~H~16~O~2~       Senkyunolide A
  72   18.17   301.2398               301.2373               0.82                                  (−)239,169                      C~16~H~32~O~2~       Palmitic acid
  73   18.2    277.1474               277.1445               1.5     301.1463   301.141    1.8     (−)147,134,121, (+)245          C~16~H~22~O~4~       Dibutyl phthalate
  74   18.25                                                         191.1062   191.1067   −0.26   (−)173,161,145,130,115,105      C~12~H~14~O~2~       Ligustilide
  75   18.62                                                         273.1124   273.1097   0.99    (+)241,140,105                  C~14~H~18~O~4~       Dipropylphtalate
  76   18.87                                                         268.1068   268.104    1       (+)119,105                      C~10~H~13~N~5~O~4~   Adenosine
  77   18.88                                                         245.121    245.1172   1.51    (+)189,131                      C~15~H~16~O~3~       Osthole
  78   18.91   353.2713               353.2686               0.75                                  (−)335,239,211,183              C~20~H~36~O~2~       Ethyl linoleate
  79   18.91                                                         189.0543   189.0522   1.11    (+)152,131,115,103              C~9~H~10~O~3~        Paeonol
  80   19.05   199.1335               199.1329               0.3                                   (−)164                          C~10~H~18~O          Eucalyptol
  81   19.11                                                         329.1372   329.1384   −0.36   (+)229,187,175,159,131          C~19~H~20~O~5~       Columbianadin
  82   20.26                                                         381.206    381.206    0       (+)231,189                      C~24~H~28~O~4~       Levistilide A
  83   20.28                                                         335.1915   335.1853   1.8     (+)317,207                      C~19~H~26~O~5~       Rubrosterone
  84   20.69                                                         577.4143   577.4463   −5.51   (+)560,448,278,234,133          C~35~H~60~O~6~       Daucosterol
  85   20.85   455.3541               455.3531               0.22                                  (−)391                          C~30~H~48~O~3~       Oleanolic acid
  86   21.48                                                         463.3024   463.3054   −0.65   (+)337,319                      C~27~H~42~O~6~       Stachysterone D
  87   22.59                                                         353.2686   353.2662   0.68    (+)186                          C~19~H~38~O~4~       Monopalmitin
  88   24.66   281.2496               281.2486               0.36                                  (−)223,207                      C~18~H~34~O~2~       Oleic acid

Compounds selection for quantitative analysis {#s0018}
---------------------------------------------

As shown in the literature, catechin could reduce inflammation and slow cartilage breakdown (Adcocks et al. [@CIT0002]), paeoniflorin could down regulate the levels of TNF-α and myeloperoxidase, and reduce the production of IL-6 in LPS-simulated mouse macrophage RAW264.7 cells (Zhang et al. [@CIT0026]). Other research indicated that paeoniflorin inhibited intercellular adhesion molecule-1 expression in LPS-treated U937 cells and TNF-α-stimulated human umbilical vein endothelial cells by suppressing the activation of the NF-κB pathway (Jin et al. [@CIT0011]). Hyperoside could significantly decrease the mRNA expression and production of IL-1β, IL-6 in stimulated HMC-1 cells (Han et al. [@CIT0009]). Ferulic acid may offer beneficial effects against osteoarthritis (Li et al. [@CIT0014]), and ferulic acid has chondroprotective effects on hydrogen peroxide-stimulated chondrocytes through depressing hydrogen peroxide-induced pro-inflammatory cytokines and metalloproteinase gene expression at the mRNA level (Chen et al. [@CIT0003]). Polydatin has efficacious anti-inflammatory activity by attenuating the phosphorylation of ERK1/2, JNK, and p38 (Lou et al. [@CIT0017]). Quercetin could ameliorate all markers of inflammation (Gardi et al. [@CIT0008]). Research suggested that MAPK signaling factors were involved in inflammation, quercetin inhibited the MAPK signal factors in macrophages, and quercetin also inhibited the secretion of the inflammatory cytokines IL-1β, IL-6, and stimulated the anti-inflammatory cytokine IL-10 (Seo et al. [@CIT0022]). Based on the research, proinflammatory cytokines in the cartilage and synovium will stimulate their own production and induce chondrocytes to produce some abnormal biomechanical forces, such as proteases, chemokines, and nitric oxide, which will result in an imbalance between the chondrocyte anabolic and catabolic pathways, and ultimately leads to progressive joint destruction. Resveratrol keeps chondrocyte from apoptosis and reverses the catabolic state of chondrocytes in OA pathway (Dave et al. [@CIT0007]). Due to its antiapoptotic, anti-inflammatory, and antioxidant properties, resveratrol have anti-osteoarthritic effects (Shen et al. [@CIT0023]). Inflammatory cytokine IL-1β is one of the key inflammatory factors in intervertebral disc degeneration, psoralen could remit the degeneration of intervertebral disc chondrocyte induced by IL-1β (Yang et al. [@CIT0025]), it also significantly suppressed T helper 2 cytokines of IL-4, IL-5, and IL-13 by ConA-stimulated D10 cells without inhibitory effect on cell viability (Jin et al. [@CIT0010]). Isopsoralen was being used for its central inhibitory activities and inhibitory role in cell proliferation and antimicrobial (Liu et al. [@CIT0015]). Icariside II exhibits anti-inflammatory activity, but its molecular pathways in human cells are poorly understood (Kim et al. [@CIT0013]). Osthole can prevent isoprenalin-induced myocardial fibrosis in mice, and the mechanisms perhaps related to the reduction of TGF-β1 expression (Chen et al. [@CIT0004]), osthole could also enhance osteoclasts apoptotic and inhibit the bone resorption through RANK + RANKL/TRAF6/Mkk/JNK signal pathway (Ming et al. [@CIT0019]). TNF-α is a major inflammatory cytokine that mediates immune responses and systemic inflammation. Isoimperatorin inhibits TNF-α-induced expression of VCAM-1, therefore, isoimperatorin can be used for the treatment of pathologic inflammatory disorders (Moon et al. [@CIT0020]).

Through the review of the literature, we selected above described 12 active compounds with potential in treating OA and inhibiting chondrocyte apoptosis from these 88 compounds above, which were identified by HPLC-ESI-Q-TOF-MS for qualitative analysis. Chemical structures of these 12 compounds are shown in [Figure 2](#F0002){ref-type="fig"}.

![Chemical structures of 12 compounds determined simultaneously.](IPHB_A_1285327_F0002_B){#F0002}

Quantitative analysis {#s0019}
---------------------

UPLC-ESI-TQ-MS technology was used to determine the contents of catechin, paeoniflorin, hyperoside, ferulic acid, polydatin, quercetin, resveratrol, psoralen, isopsoralen, icariside II, osthole, and isoimperatorin. LC-MS/MS chromatogram of the 12 compounds in BSHXD is given in [Figure 3](#F0003){ref-type="fig"}, and their contents in the single herbs and decoction were summarized in [Table 2](#t0002){ref-type="table"}. The standard curves and linear ranges of these 12 compounds are shown in [Table 3](#t0003){ref-type="table"}. The precision and the accuracy were validated by the determination of the peak areas of compounds of interest during the preparation procedure. Relative standard deviation (RSD) of each compound was lower than 3%, the results showed that the method displays good precision and accuracy for each compound. The stabilities of these 12 compounds were tested at 0, 2, 4, 6, 12, and 24 h, RSD values of the peak areas were all no more than 3%, that revealed that the compounds were stable within 24 h. BSHXD sample was made into six solutions, inject 2 μL each time, and MS chromatography was used to determine the contents of each compound. The average content of catechin was 0.0411 mg/g, paeoniflorin was 4.2455 mg/g, hyperoside was 0.1199 mg/g, ferulic acid was 0.0576 mg/g, polydatin was 0.7589 mg/g, quercetin was 0.2001 mg/g, resveratrol was 0.1567 mg/g, psoralen was 0.8863 mg/g, isopsoralen was 0.4598 mg/g, icariside II was 0.0919 mg/g, osthole was 0.5274 mg/g, and isoimperatorin was 0.1490 mg/g, and RSD values were all less than 3%, indicating that the method was stable.

![LC-MS/MS chromatogram of the 12 compounds in BSHXD. Retention time (RT): **1**→Catechin (1.61 min), **2**→Paeoniflorin (2.70 min), **3**→Hyperoside (3.23 min), **4**→Ferulic acid (3.28 min), **5**→Polydatin(4.43 min), **6**→Quercetin (5.73 min), **7**→Resveratrol (6.09 min), **8**→Psoralen (6.50 min), **9**→Isopsoralen (6.82 min), **10**→IcarisideII (9.75 min), **11**→Osthole (11.16 min), and **12**→Isoimperatorin (11.44 min).](IPHB_A_1285327_F0003_C){#F0003}

###### 

Content determination of the samples (mg/g, *n* = 3).

  Compounds        *Angelicae Pubescentis Radix*   *Taxilli Herba*   *Achyranthis Bidentatae Radix*   *Epimedii Folium*   *Chuanxiong Rhizoma*   *Angelicae Sinensis Radix*   *Paeoniae Radix Alba*   *Polygoni Cuspidati Rhizoma Et Radix*   *Arisaematis RhizomaPreparatum*   BSHXD
  ---------------- ------------------------------- ----------------- -------------------------------- ------------------- ---------------------- ---------------------------- ----------------------- --------------------------------------- --------------------------------- --------
  Catechin                                                                                                                                                                                            0.0489                                                                    0.0422
  Paeoniflorin                                                                                                                                                                5.2222                                                                                            4.2596
  Hyperoside                                                                                          0.7591                                                                                                                                                                    0.1211
  Ferulic acid                                                                                                            0.0411                 0.0913                                                                                                                         0.0584
  Polydatin                                                                                                                                                                                           12.5807                                                                   0.7594
  Quercetin                                        0.0662                                                                                                                                             0.0101                                                                    0.1999
  Resveratrol                                                                                                                                                                                         0.5818                                                                    0.1570
  Psoralen         0.9954                                                                                                                                                                                                                                                       0.8948
  Isopsoralen      0.3765                                                                                                                                                                                                                                                       0.4634
  IcarsideII                                                                                          0.0322                                                                                                                                                                    0.0928
  Osthole          0.1087                                                                                                                                                                                                                                                       0.5364
  Isoimperatorin   0.0763                                                                                                                                                                                                                                                       0.1487

###### 

Standard curve and linear range of each compound.

  Number   Rt (min)   Compounds        Regression equation        *R*^2^   Linear range (μg/mL)
  -------- ---------- ---------------- -------------------------- -------- ----------------------
  1        1.61       Catechin         *Y* = 6079.2*x* − 204.2    0.9998   0.0106--3.5698
  2        2.70       Paeoniflorin     *Y* = 5320.8*x* + 114.38   0.9997   0.0404--14.074
  3        3.23       Hyperoside       *Y* = 6692.6*x* − 595.73   0.9999   0.0994--3.8286
  4        3.28       Ferulic acid     *Y* = 19721*x* − 1927.6    0.9984   0.0987--1.8724
  5        4.43       Polydatin        *Y* = 16912*x* − 226.29    0.9990   0.0100--4.5306
  6        5.73       Quercetin        *Y* = 50207*x* − 1707      0.9993   0.0350--3.9307
  7        6.09       Resveratrol      *Y* = 1689.5*x* − 70.719   0.9998   0.1259--3.8672
  8        6.50       Psoralen         *Y* = 273637*x* − 3207.9   0.9978   0.0196--4.7626
  9        6.82       Isopsoralen      *Y* = 336719*x* − 9923.6   0.9999   0.0400--3.8719
  10       9.75       Icariside II     *Y* = 271366*x* − 3081.3   0.9996   0.0100--0.9741
  11       11.16      Osthole          *Y* = 1233900*x* − 69509   0.9989   0.0201--5.2790
  12       11.44      Isoimperatorin   *Y* = 88731*x* − 7657.9    0.9979   0.0708--1.9528

ELISA results {#s0020}
-------------

TNF-α, IL-6, and NO play an important role in cells, tissues, and organs, respectively. Within cartilage, pro-inflammatory cytokines such as TNF-α auto-catalytically stimulate its production and induce chondrocytes to produce additional catabolic mediators that abnormal biomechanical forces will lead to progressive joint destruction (Abramson & Yazici [@CIT0001]). IL-6-signal transducer may conduce to the posttraumatic development of osteoarthritis (Liu et al. [@CIT0016]), and IL-6 can be considered as a marker of nerve injury and proinflammatory cytokines which produced by joint tissue (Malek et al. [@CIT0018]). Imbalance of catabolic and anabolica factors including cytokines and NO could result in OA (Chevalier et al. [@CIT0005]). In that case, TNF-α, IL-6, and NO were utilized to explore the mechanism of BSHXD in treating OA. Changes of released inflammatory mediators' concentration were observed by ELISA. It is shown that quercetin, isopsoralen, icariside II, osthole, isoimperatorin, and BSHXD have different effects in inhibiting the release of TNF-α, IL-6, and NO. Quercetin (100 μg/mL), isopsoralen (100 μg/mL), icariside II (100 μg/mL), osthole (20 and 100 μg/mL), isoimperatorin (100 μg/mL), and BSHXD (100 μg/mL) had a significant inhibition effect on the release of TNF-α, *p* \< 0.01; quercetin (20 and 100 μg/mL), isopsoralen (100 μg/mL), icariside II (100 μg/mL), osthole (20 and 100 μg/mL), and isoimperatorin (20 and 100 μg/mL) had a significant inhibition effect on the release of IL-6, *p* \< 0.01; five compounds (20 and 100 μg/mL) and BSHXD (100 μg/mL) had a remarkable inhibition effect on the release of NO, *p* \< 0.01. The results showed that the monomers hold generally stronger inhibition effect than BSHXD. [Tables 4--6](#t0004 t0005 t0006){ref-type="table"} describe the detailed inhibition results of these components of decoction on TNF-α, IL-6, and NO released by RAW264.7 cell after induction of LPS.

###### 

The inhibition of different components on TNF-α released by RAW264.7 cell after induction of LPS.

  Group            Concentration (μg/mL)   Inhibition (%)
  ---------------- ----------------------- -----------------------------------------
  Control          --                      --
  LPS              0.5                     --
  Quercetin        20                      5.86
                   100                     57.68[\*\*](#TF3){ref-type="table-fn"}
  Isopsoralen      20                      16.48[\*](#TF2){ref-type="table-fn"}
                   100                     64.38[\*\*](#TF3){ref-type="table-fn"}
  IcarisidII       20                      58.17[\*\*](#TF3){ref-type="table-fn"}
                   100                     103.79[\*\*](#TF3){ref-type="table-fn"}
  Osthole          20                      90.58[\*\*](#TF3){ref-type="table-fn"}
                   100                     104.05[\*\*](#TF3){ref-type="table-fn"}
  Isoimperatorin   20                      17.54[\*](#TF2){ref-type="table-fn"}
                   100                     49.4[\*\*](#TF3){ref-type="table-fn"}
  BSHXD            20                      1.54
                   100                     35.75[\*\*](#TF3){ref-type="table-fn"}

x ± s, *n* = 3, groups compared with the LPS model control group.

*p* \< 0.05.

*p* \< 0.01.

###### 

The inhibition of different components on IL-6 released by RAW264.7 cell after induction by LPS.

  Group            Concentration (μg/mL)   Inhibition (%)
  ---------------- ----------------------- -----------------------------------------
  Control          --                      --
  LPS              0.5                     --
  Quercetin        20                      29.45[\*\*](#TF6){ref-type="table-fn"}
                   100                     79.73[\*\*](#TF6){ref-type="table-fn"}
  Isopsoralen      20                      18.66[\*](#TF5){ref-type="table-fn"}
                   100                     91.15[\*\*](#TF6){ref-type="table-fn"}
  IcarisidII       20                      1.64
                   100                     99.03[\*\*](#TF6){ref-type="table-fn"}
  Osthole          20                      99.37[\*\*](#TF6){ref-type="table-fn"}
                   100                     100.03[\*\*](#TF6){ref-type="table-fn"}
  Isoimperatorin   20                      64.23[\*\*](#TF6){ref-type="table-fn"}
                   100                     67.39[\*\*](#TF6){ref-type="table-fn"}
  BSHXD            20                      0.60
                   100                     13.11[\*](#TF5){ref-type="table-fn"}

x ± s, *n* = 3, groups compared with the LPS model control group.

*p* \< 0.05.

*p* \< 0.01.

###### 

The inhibition of different components on NO released by RAW264.7 cell after induction by LPS.

  Group           Concentration (μg/mL)   Inhibition (%)
  --------------- ----------------------- ----------------------------------------
  Control         --                      --
  LPS             0.5                     --
  Quercetin       20                      73.18[\*\*](#TF9){ref-type="table-fn"}
                  100                     77.29[\*\*](#TF9){ref-type="table-fn"}
  Isopsoralen     20                      93.46[\*\*](#TF9){ref-type="table-fn"}
                  100                     81.31[\*\*](#TF9){ref-type="table-fn"}
  IcarisidII      20                      61.03[\*\*](#TF9){ref-type="table-fn"}
                  100                     89.44[\*\*](#TF9){ref-type="table-fn"}
  Osthole         20                      77.29[\*\*](#TF9){ref-type="table-fn"}
                  100                     89.44[\*\*](#TF9){ref-type="table-fn"}
  Isoimperation   20                      52.90[\*\*](#TF9){ref-type="table-fn"}
                  100                     65.05[\*\*](#TF9){ref-type="table-fn"}
  BSHXD           20                      16.26[\*](#TF8){ref-type="table-fn"}
                  100                     56.92[\*\*](#TF9){ref-type="table-fn"}

x ± s, *n* = 3, groups compared with the LPS model control group.

*p* \< 0.05.

*p* \< 0.01.

Conclusion {#s0021}
==========

According to LC-MS/MS analysis, 88 compounds from BSHXD were confirmed. Twelve compounds which have a potential role in treating OA were selected and quantified. By comparing the contents of 12 compounds in BSHXD and single herbs, we found that five of them increased significantly. Therefore, the anti-inflammatory activity *in vitro* was tested. ELISA was used to detect the effect of quercetin, isopsoralen, icariside II, osthole, isoimperatorin, and BSHXD on TNF-α, IL-6, and NO released by macrophage, we found that the compounds had some or remarkably inhibitory effect on the former cytokines, which may demonstrate the possible reason and mechanism of BSHXD in treating OA.

In traditional Chinese medicine theory, the fact that different herbs used in combination can enhance the therapeutic efficacy compared with those when they were used separately is called 'Xiang Xu'. In BSHXD, nine herbs which have different therapeutic effects were decocted together, and the results of UPLC-ESI-TQ-MS showed the contents of compounds of interest increased or decreased, which may be due to certain chemical reactions occurred among the chemical constituents in the herbs. That means that the contents of some compounds which have potential therapeutic effects on OA were higher in decoction than in single herb that may give rise to reinforcement of therapeutic effects on OA.
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